Detalhe da pesquisa
1.
Mammalian ISWI and SWI/SNF selectively mediate binding of distinct transcription factors.
Nature
; 569(7754): 136-140, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996347
2.
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.
Blood
; 138(5): 370-381, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33786580
3.
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.
Cancer Cell
; 42(4): 583-604.e11, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458187
4.
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions.
Cancer Cell
; 42(4): 605-622.e11, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458188
5.
Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight.
Nat Commun
; 15(1): 4954, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38862516
6.
Epigenetic modulation of the HeLa cell membrane N-glycome.
Biochim Biophys Acta
; 1820(9): 1412-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22192783
7.
ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.
bioRxiv
; 2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546906
8.
BTG1 mutation yields supercompetitive B cells primed for malignant transformation.
Science
; 379(6629): eabj7412, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656933
9.
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.
Cancer Cell
; 42(4): 720-722, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593783
10.
Inhibition of DNA methylation alters chromatin organization, nuclear positioning and activity of 45S rDNA loci in cycling cells of Q. robur.
PLoS One
; 9(8): e103954, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25093501
11.
Reversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors.
PLoS One
; 8(1): e54672, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23336012